An open-label phase I study to evaluate the safety, tolerability and preliminary efficacy of YY001 in patients with advanced solid tumors

被引：0
|
作者：
Xue, Liqiong
Tang, Wenbo
Zhou, Huan
Liu, Mulin
Liu, Yuanyuan
Wang, Jinhua
Chen, Jianfeng
Liu, Mingyao
Guo, Ye
机构：
[1] Tongji Univ, Shanghai East Hosp, Sch Med, Shanghai, Peoples R China
[2] Tongji Univ, Shanghai East Hosp, Sch Med, Dept Oncol, Shanghai, Peoples R China
[3] Bengbu Med Univ, Affiliated Hosp 1, Bengbu, Peoples R China
[4] Shanghai Yuyao Biotech Co Ltd, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15104
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase I Open-Label Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Dilpacimab in Patients with Advanced Solid Tumors
    Gordon, Michael S.
    Nemunaitis, John
    Barve, Minal
    Wainberg, Zev A.
    Hamilton, Erika P.
    Ramanathan, Ramesh K.
    Sledge, George W., Jr.
    Yue, Huibin
    Morgan-Lappe, Susan E.
    Blaney, Martha
    Kasichayanula, Sreeneeranj
    Motwani, Monica
    Wang, Lan
    Naumovski, Louie
    Strickler, John H.
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (10) : 1988 - 1995
  • [2] Open-Label, Multicenter, Phase I Study to Assess Safety and Tolerability of Adavosertib Plus Durvalumab in Patients with Advanced Solid Tumors
    Patel, Manish R.
    Falchook, Gerald S.
    Wang, Judy S.
    Imedio, Esteban Rodrigo
    Kumar, Sanjeev
    Miah, Kowser
    Mugundu, Ganesh M.
    Jones, Suzanne F.
    Spigel, David R.
    Hamilton, Erika P.
    TARGETED ONCOLOGY, 2025, 20 (01) : 127 - 138
  • [3] Safety, tolerability, pharmacokinetics, and antitumor activity of adavosertib in Japanese patients with advanced solid tumors: A phase I, open-label study
    Kondo, Shunsuke
    Katsuya, Yuki
    Yonemori, Kan
    Komuro, Keiko
    Sugeno, Masatoshi
    Kawata, Toshio
    Ghiorghiu, Dana
    Meulendijks, Didier
    Yamamoto, Noboru
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2024, 39
  • [4] MOVIE: a phase I, open-label, multicenter study to evaluate the safety and tolerability of metronomic vinorelbine combined with durvalumab plus tremelimumab in patients with advanced solid tumors
    Vicier, C.
    Isambert, N.
    Cropet, C.
    Hamimed, M.
    Osanno, L.
    Legrand, F.
    Rouge, T. de La Motte
    Ciccolini, J.
    Goncalves, A.
    ESMO OPEN, 2022, 7 (06)
  • [5] A phase I/II, open-label, multicenter study to evaluate the safety, pharmacokinetics, pharmacodynamics, and efficacy of HB0036 in patients with advanced solid tumors
    Sun, Yuping
    Yu, Jinming
    Tolcher, Anthony W.
    Albany, Costantine
    Chaudhry, Arvind
    Dang, Qi
    Ye, Leiguang
    Yang, Fang
    Liu, Baogang
    Sun, Longhua
    Tang, Jianjun
    Xu, Lei
    Zhu, Xiangyang
    Yang, Yongmin
    Yang, Yang
    Zhan, Yifan
    Li, Benke
    Hou, Kexin
    Zheng, Yang, Sr.
    Wang, Jingjing
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Open-label, multicenter, phase I study to assess safety and tolerability of adavosertib plus durvalumab in patients with advanced solid tumors.
    Patel, Manish R.
    Falchook, Gerald Steven
    Wang, Judy Sing-Zan
    Imedio, Esteban Rodrigo
    Kumar, Sanjeev
    Motlagh, Pejvack
    Miah, Kowser
    Mugundu, Ganesh M.
    Jones, Suzanne Fields
    Spigel, David R.
    Hamilton, Erika Paige
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [7] A Multicenter, Open-Label Phase 1 Trial to Evaluate Safety, Tolerability, and Pharmacokinetics of ICP-723 in Patients with Advanced Solid Tumors
    Zhang, Jun
    Chavez, Jorge
    Chan, Nancy
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E27 - E27
  • [8] An open label phase I study to evaluate the safety and efficacy of OBP-301 with pembrolizumab in patients with advanced solid tumors.
    Kojima, Takashi
    Fujiwara, Toshiyoshi
    Shirakawa, Yasuhiro
    Ono, Hiromi
    Nakamoto, Masako
    Hasegawa, Hiromi
    Hirano, Nami
    Wakabayashi, Masashi
    Nomura, Shogo
    Togashi, Yosuke
    Nishikawa, Hiroyoshi
    Sato, Akihiro
    Ohtsu, Atsushi
    Doi, Toshihiko
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] Open-label, multicenter, Phase Ib study to assess safety, tolerability and efficacy of adavosertib monotherapy in patients with advanced solid tumors: Expansion cohorts
    Bauer, Todd M.
    Moore, Kathleen
    Rader, Janet S.
    Simpkins, Fiona
    Mita, Alain
    Beck, J. Thaddeus
    Hart, Lowell
    Chu, Quincy
    Oza, Amit
    Tinker, Anna V.
    So, Karen
    Imedio, Esteban Rodrigo
    Kumar, Sanjeev
    Mugundu, Ganesh M.
    Jenkins, Suzanne
    Chmielecki, Juliann
    Jones, Suzanne
    Spigel, David R.
    Fu, Siqing
    CANCER RESEARCH, 2019, 79 (13)
  • [10] Phase I, open-label study of olaparib plus cisplatin in patients with advanced solid tumors
    Balmana, Judith
    Tung, Nadine M.
    Isakoff, Steven J.
    Grana, Begona
    Ryan, Paula D.
    Rafi, Rezvan
    Tracy, Michael
    Winer, Eric
    Baselga, Jose
    Garber, Judy Ellen
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345